Perfeziona i miei risultati

Koronare Stent-Thrombosen : Was gibt es Neues für 2011? = Coronary stent thrombosis : What's new in 2011?

Oberhänsli, M. ; Puricel, S. ; Togni, M. ; Cook, S.

In: Herz, 2011, vol. 36, no. 3, p. 241-253

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Arroyo, Diego ; Togni, Mario ; Puricel, Serban ; Gerard, Baeriswyl ; Sonja, Lehmann ; Corpataux, Noé ; Villeneuve, Hélène ; Boute, Estelle ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Cook, Stéphane

In: Trials, 2014, vol. 15, no. 1, p. 9

Background: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting stents (BES) have been shown to be superior to first-generation paclitaxel-eluting stents (PES) and second-generation sirolimus-eluting stents (SES). However, neointimal proliferation and very late stent thrombosis is still an unresolved issue of drug-eluting stent (DES) implantation overall. The...

Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation

Vogel, Rolf ; Seiler, Christian ; Eberli, Franz R. ; Lüscher, Thomas ; Meier, Bernhard ; Jüni, Peter ; Windecker, Stephan

In: European Heart Journal, 2012, vol. 33, no. 11, p. 1334-1343

Aims Late acquired incomplete stent apposition (ISA) is more common after drug- eluting stent (DES) than bare metal stent (BMS) implantation and has been associated with vascular hypersensitivity and stent thrombosis (ST). We investigated the impact of incidentally discovered ISA as assessed by intravascular ultrasound (IVUS) 8 months after DES implantation on the long-term clinical...